A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases (2023)
Attributed to:
The Role of Cyclin-Dependent Kinase-9 Inhibition in Promoting the Resolution of Chronic Inflammation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cti2.1455
Publication URI: http://dx.doi.org/10.1002/cti2.1455
Type: Journal Article/Review
Parent Publication: Clinical & Translational Immunology
Issue: 6